High materiality8/10
ResMed price target raised to $267 from $255 at KeyBanc
Why it may matterVerify against the original reporting
Upside remains with a lift in target.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Target raised to $267; current price $240.33.
- Target: $267
- Price: $240.33
- Analyst: KeyBanc
Key facts
- 01
Target: $267
- 02
Posted price: $240.33
- 03
Analyst firm: KeyBanc
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.